Juvenile myelomonocytic leukemia radiation therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Juvenile myelomonocytic leukemia}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{Hematological malignancy histology}} {{SIB}} Category:Hematology [[Category:Ty..." |
|||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
== | ==Radiation/Radiotherapy== | ||
Radiation to the spleen does not generally result in a decrease in spleen size or reduction of platelet transfusion requirement. | |||
==References== | ==References== | ||
Revision as of 18:06, 23 January 2012
|
Juvenile myelomonocytic leukemia Microchapters |
|
Differentiating Juvenile myelomonocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Juvenile myelomonocytic leukemia radiation therapy On the Web |
|
American Roentgen Ray Society Images of Juvenile myelomonocytic leukemia radiation therapy |
|
Juvenile myelomonocytic leukemia radiation therapy in the news |
|
Risk calculators and risk factors for Juvenile myelomonocytic leukemia radiation therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Radiation/Radiotherapy
Radiation to the spleen does not generally result in a decrease in spleen size or reduction of platelet transfusion requirement.